Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla (TSLA) premarket today — Nov 7, 2025: Musk’s $1T pay wins approval; China FSD timeline, ‘terafab’ chip plan, and what to watch before the bell

Published: November 7, 2025


Key takeaways

  • TSLA is indicating higher before the open. As of 4:05 a.m. ET, Tesla traded around $453.81 in premarket, about +1.8% vs. Thursday’s close of $445.91. Shares also firmed to $452.93 in after-hours on Thursday. Premarket indications can change quickly. [1]
  • Shareholders approved Elon Musk’s record pay package. A new $1 trillion performance award passed with over 75% support at Thursday’s annual meeting in Austin. The plan is tied to aggressive targets (including valuation, robotaxis and humanoid robots). [2]
  • China FSD timing: Musk said he expects full approval of Full Self‑Driving (FSD) in China early 2026 (following partial approval this year). [3]
  • AI chips & capacity: Musk floated building a “gigantic chip fab” for Tesla’s next‑gen AI chips and said it’s “worth having discussions” with Intel on manufacturing. [4]
  • Macro risk at 8:30 a.m. ET: The U.S. Employment Situation (October) lands 60 minutes before the opening bell—often a major factor for high‑beta names like TSLA. CPI for October is due next Thursday (Nov 13). [5]

Premarket snapshot: price, context, tone

Tesla closed Thursday at $445.91 (-3.5%) after a choppy session, then firmed to $452.93 after hours and is pointing higher before today’s open around $453.81. The modest bid coincides with shareholders’ approval of Musk’s new compensation plan and optimism around Tesla’s AI/robotics roadmap. (Prices are delayed; premarket quotes are indicative.) [6]


The news moving TSLA this morning

1) Shareholders approve Musk’s $1T package

Investors gave Elon Musk a fresh, performance‑based compensation plan that could be worth up to $1 trillion over the next decade if Tesla meets sweeping milestones. Multiple outlets report more than 75% of votes were cast in favor. The plan sharpens Tesla’s pivot from a pure EV story toward AI, robotaxis (“Cybercab”), humanoid robots (Optimus) and energy/compute at massive scale. [7]

Why it matters:

  • The vote reduces near‑term uncertainty over Musk’s commitment and influence at Tesla.
  • Governance debate isn’t going away, but bulls see the approval as clearing a path for the AI/robotics valuation narrative to stay front‑and‑center. [8]

2) China FSD: full approval “early 2026”

Musk told shareholders he expects full regulatory approval for FSD in China in February–March 2026, after partial approval earlier this year. China remains Tesla’s most strategically vital overseas market; broader FSD availability there would open new software revenue and data advantages. [9]

3) Musk floats a Tesla “terafab” for AI chips; open to Intel discussions

At the meeting, Musk said Tesla likely needs a “gigantic chip fab” to build its AI5 (and beyond) inference/training chips at volume, adding it’s “worth having discussions” with Intel on manufacturing. He also referenced TSMC and Samsung as ongoing partners. A home‑grown chip ramp could ease dependence on third‑party supply and sharpen Tesla’s AI margins over time—execution and capex will be the swing factors. [10]

4) Product roadmap notes from the meeting

Coverage of the event highlighted timelines Musk reiterated or teased: Cybercab (robotaxi) production targeted for April 2026, the next‑gen Roadster unveiling in April 2026, and plans to scale Optimus. Timelines remain ambitious and conditional on regulatory and manufacturing readiness. [11]


Today’s market setup: what matters before the bell

  • Jobs report (8:30 a.m. ET): The October Employment Situation can sway yields and high‑beta tech. A “hot” print tends to lift rates and weigh on long‑duration growth stocks; a “cool” print can do the opposite. Keep an eye on the two‑year and 10‑year Treasury moves into the open. CPI (Oct) follows on Thursday, Nov 13—another macro catalyst for risk appetite. [12]
  • Positioning into weekly expiry:Nov‑7 weekly TSLA options show heavy interest in near‑the‑money calls (e.g., $450–$455 strikes appearing among the morning’s most active contracts), underscoring a trader focus on a post‑vote pop and macro‑headline volatility. (Options activity is dynamic; check live screens.) [13]

How to frame TSLA right now

Bull case this morning: Governance overhang eases; China FSD path gets a clearer timeline; AI chip capacity plans reinforce the “physical AI” thesis (robotaxis, humanoids, energy + software). If the jobs report is benign and yields stay contained, the backdrop could support a bid in high‑beta mega caps—TSLA included. [14]

Bear case / Risks: Execution remains enormous—regulatory approvals (especially for Cybercab/FSD in multiple jurisdictions), capex intensity for chips and robotics, and a still‑competitive global EV market. The governance debate isn’t settled for skeptics; some large institutions remain critical of concentration of power and dilution concerns. Macro (jobs/CPI) can quickly overwhelm single‑name narratives intraday. [15]


By the numbers (as you head into the open)

  • Thursday close:$445.91
  • After‑hours (Thu):$452.93 (~+1.6% vs. close)
  • Premarket (Fri ~4:05 a.m. ET):$453.81 (~+1.8% vs. close)
    (All quotes delayed; premarket levels move rapidly.) [16]

Bottom line

Going into the Nov 7 open, TSLA is trading the post‑vote narrative: Musk stays, AI/robotics push intensifies, China FSD timeline firmed up, and chip capacity ambitions escalate. Near‑term price action likely pivots on the 8:30 a.m. ET jobs report and whether broader risk sentiment cooperates. For now, the tape points modestly higher as bulls try to lean into the newly re‑centered AI + autonomy story. [17]


Disclosure: This article is for news and informational purposes only and does not constitute investment advice. Always do your own research and consider your risk tolerance before trading or investing.

The Biggest Week in Tesla Stock's History... (WATCH ASAP)

References

1. www.marketwatch.com, 2. www.reuters.com, 3. www.reuters.com, 4. www.reuters.com, 5. www.bls.gov, 6. www.marketwatch.com, 7. www.reuters.com, 8. www.businessinsider.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.investors.com, 12. www.bls.gov, 13. www.nasdaq.com, 14. www.reuters.com, 15. www.businessinsider.com, 16. www.marketwatch.com, 17. www.reuters.com

Stock Market Today

  • Pool Corp Named a Top 25 Dividend Giant With 2.01% Yield
    November 7, 2025, 8:52 AM EST. Pool Corp (ticker: POOL) was named a Top 25 Dividend Giant by ETF Channel, supported by $58.66B in ETF ownership and a solid 2.01% yield. The DividendRank metrics highlight a long-running quarterly dividend history and favorable multi-year growth in key fundamentals. The stock pays an annualized $5 dividend, distributed quarterly, with the latest ex-dividend date recorded as 11/12/2025. As ETF ownership underscores steady income demand, investors may weigh past dividend reliability when assessing whether the current payout can continue amid the firm's growth trajectory. The study sits among the broader list of Dividend Giants widely held by ETFs.
  • FHLC Implied Target at $81.28: Analysts See ~16% Upside While XERS/MLYS/IRMD Stand Out
    November 7, 2025, 8:50 AM EST. Analysts using ETF Channel data peg the Fidelity MSCI Health Care Index ETF (FHLC) at an implied target of $81.28, versus a recent price near $70.14. That equates to about 15.88% upside to the target. Among FHLC's holdings, Xeris Biopharma (XERS) shows the strongest upside with a target of $10.67 (from $7.72, 38.16% higher); Mineralys Therapeutics (MLYS) targets $45.00 (vs $37.01, 21.59%); and iRadimed (IRMD) targets $99.00 (vs $84.57, 17.06%). The article notes questions about whether these targets are justified and warns that lofty targets can precede downgrades, suggesting investors perform further research.
  • TRGP Named Top Socially Responsible Dividend Stock by Dividend Channel
    November 7, 2025, 8:48 AM EST. TRGP has been named a Top Socially Responsible Dividend Stock by Dividend Channel, highlighting a DividendRank-driven profile with a 2.4% yield. The designation reflects ESG considerations-environmental, social, and governance criteria-used by asset managers when assessing investments. TRGP also appears in ESG-focused ETFs: SUSA (0.72% of holdings) and DSI (0.14%). The stock pays an annualized dividend of $4 per share, quarterly, with the ex-date on 10/31/2025. Operates in the Oil & Gas Refining & Marketing sector. The article notes the importance of dividend history in judging the likelihood of continued payments, and positions TRGP among peers like CVX and SU.
  • EXC Named a Top 10 Dividend-Paying Utility Stock by Dividend Channel
    November 7, 2025, 8:46 AM EST. Exelon Corp (EXC) has been named a Top 10 dividend-paying utility stock by Dividend Channel's weekly DividendRank report, highlighting a favorable mix of valuations and profitability. The stock trades around $45.71 with a price-to-book of 1.6 and yields 3.50% annually, versus the utility universe average of 3.4% yield and 2.8x P/B. The report emphasizes EXC's strong quarterly dividend history and solid long-term growth metrics. DividendRank aims to identify the most profitable, attractively valued names for further research. Exelon's annualized dividend is $1.6 per share, paid quarterly, with the most recent ex-dividend date listed as 11/10/2025. Investors eyeing value and income may view EXC as a compelling idea within the utility space.
  • Marsh & McLennan Stock Prediction: Analysts See ~21% Upside by 2027
    November 7, 2025, 8:44 AM EST. Marsh & McLennan (NYSE: MMC) trades near $177 and faces modest upside according to analysts. The average target ~ $214 implies about 21% upside, with a tight range (high $258, low $181) and a mix of 4 Buys, 2 Outperforms, 14 Holds, 1 Underperform, 1 Sell. The story centers on steady fundamentals: revenue growth of 6-7% annually through 2027, potential operating margins approaching 27%, and a forward P/E around 18x. TIKR's Guided Valuation Model suggests a ~$215 by 2027 (about 9.5% annualized returns). The stock is viewed as a stable, high-quality compounder, with dividend growth and disciplined capital management offsetting risks of multiple expansion. Investors expect reliable earnings growth rather than aggressive expansion, with MMC likely to outperform in stable markets but limited upside without accelerating earnings.
Saudi Aramco Stock Analysis 2025: Is the Oil Giant Still Worth Your Money?
Previous Story

Saudi Aramco (2222.SR) — Before Market Open Today (Nov 7, 2025): Oil Rebounds But Heads for Weekly Loss, Aramco Cuts Asian OSPs, and Q3 Dividend Dates to Watch

Meta’s AI Revolution Unleashed: July 2025 Breakthroughs, Billion‑Dollar Bets & Backlash
Next Story

Meta Platforms (META) Pre‑Market Update Today — November 7, 2025: Reuters scam‑ads bombshell, fresh AI‑training lawsuit, and what it means for the stock

Go toTop